Cargando…
Circulating thyrotropin receptor messenger ribonucleic acid is not an effective marker in the follow-up of differentiated thyroid carcinoma
BACKGROUND: Circulating thyrotropin receptor messenger ribonucleic acid (TSHR mRNA) assay has been validated in the follow-up of differentiated thyroid carcinoma (DTC) because of its high sensitivity during thyroid hormone therapy and no interference with endogenous anti-thyroglobulin antibodies (Tg...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523908/ https://www.ncbi.nlm.nih.gov/pubmed/26244057 http://dx.doi.org/10.1186/s13044-015-0024-4 |
_version_ | 1782384132907597824 |
---|---|
author | Ausavarat, Surasawadee Sriprapaporn, Jiraporn Satayaban, Busara Thongnoppakhun, Wanna Laipiriyakun, Aunchalee Amornkitticharoen, Boontham Chanachai, Rujaporn Pattanachak, Chaveevan |
author_facet | Ausavarat, Surasawadee Sriprapaporn, Jiraporn Satayaban, Busara Thongnoppakhun, Wanna Laipiriyakun, Aunchalee Amornkitticharoen, Boontham Chanachai, Rujaporn Pattanachak, Chaveevan |
author_sort | Ausavarat, Surasawadee |
collection | PubMed |
description | BACKGROUND: Circulating thyrotropin receptor messenger ribonucleic acid (TSHR mRNA) assay has been validated in the follow-up of differentiated thyroid carcinoma (DTC) because of its high sensitivity during thyroid hormone therapy and no interference with endogenous anti-thyroglobulin antibodies (TgAb) compared to serum thyroglobulin (Tg). We investigated the efficacy of TSHR mRNA assay in 160 DTC patients using quantitative PCR (qPCR). FINDINGS: Only TSHR mRNA level of structural persistent disease with TgAb-positive (3.47 (2.97–9.53) pg equivalents/μg total RNA; p = 0.013) and its subgroup of distant metastasis patients with TgAb-positive (5.55 (3.28–12.52) pg equivalents/μg total RNA; p = 0.009) were significantly different from patients with no evidence of disease (2.32 (1.44–3.94) pg equivalents/μg total RNA). Applying cutoff at 2.00 pg equivalents/μg total RNA enabled us to predict structural persistent disease patients with a sensitivity of 62.3 % and a specificity of 42.9 %. Although, the sensitivity of TSHR mRNA assay in TgAb-postive patients (88.2 %) was superior than serum Tg (47.1 %) (p = 0.00002), the accuracy of the test is only 54.5 %. CONCLUSIONS: This study demonstrated that TSHR mRNA assay has good sensitivity in TgAb-positive patients but it is neither specific enough as a first-line of testing nor a surrogate marker in the follow-up of our DTC patients. |
format | Online Article Text |
id | pubmed-4523908 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-45239082015-08-05 Circulating thyrotropin receptor messenger ribonucleic acid is not an effective marker in the follow-up of differentiated thyroid carcinoma Ausavarat, Surasawadee Sriprapaporn, Jiraporn Satayaban, Busara Thongnoppakhun, Wanna Laipiriyakun, Aunchalee Amornkitticharoen, Boontham Chanachai, Rujaporn Pattanachak, Chaveevan Thyroid Res Short Report BACKGROUND: Circulating thyrotropin receptor messenger ribonucleic acid (TSHR mRNA) assay has been validated in the follow-up of differentiated thyroid carcinoma (DTC) because of its high sensitivity during thyroid hormone therapy and no interference with endogenous anti-thyroglobulin antibodies (TgAb) compared to serum thyroglobulin (Tg). We investigated the efficacy of TSHR mRNA assay in 160 DTC patients using quantitative PCR (qPCR). FINDINGS: Only TSHR mRNA level of structural persistent disease with TgAb-positive (3.47 (2.97–9.53) pg equivalents/μg total RNA; p = 0.013) and its subgroup of distant metastasis patients with TgAb-positive (5.55 (3.28–12.52) pg equivalents/μg total RNA; p = 0.009) were significantly different from patients with no evidence of disease (2.32 (1.44–3.94) pg equivalents/μg total RNA). Applying cutoff at 2.00 pg equivalents/μg total RNA enabled us to predict structural persistent disease patients with a sensitivity of 62.3 % and a specificity of 42.9 %. Although, the sensitivity of TSHR mRNA assay in TgAb-postive patients (88.2 %) was superior than serum Tg (47.1 %) (p = 0.00002), the accuracy of the test is only 54.5 %. CONCLUSIONS: This study demonstrated that TSHR mRNA assay has good sensitivity in TgAb-positive patients but it is neither specific enough as a first-line of testing nor a surrogate marker in the follow-up of our DTC patients. BioMed Central 2015-08-04 /pmc/articles/PMC4523908/ /pubmed/26244057 http://dx.doi.org/10.1186/s13044-015-0024-4 Text en © Ausavarat et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Short Report Ausavarat, Surasawadee Sriprapaporn, Jiraporn Satayaban, Busara Thongnoppakhun, Wanna Laipiriyakun, Aunchalee Amornkitticharoen, Boontham Chanachai, Rujaporn Pattanachak, Chaveevan Circulating thyrotropin receptor messenger ribonucleic acid is not an effective marker in the follow-up of differentiated thyroid carcinoma |
title | Circulating thyrotropin receptor messenger ribonucleic acid is not an effective marker in the follow-up of differentiated thyroid carcinoma |
title_full | Circulating thyrotropin receptor messenger ribonucleic acid is not an effective marker in the follow-up of differentiated thyroid carcinoma |
title_fullStr | Circulating thyrotropin receptor messenger ribonucleic acid is not an effective marker in the follow-up of differentiated thyroid carcinoma |
title_full_unstemmed | Circulating thyrotropin receptor messenger ribonucleic acid is not an effective marker in the follow-up of differentiated thyroid carcinoma |
title_short | Circulating thyrotropin receptor messenger ribonucleic acid is not an effective marker in the follow-up of differentiated thyroid carcinoma |
title_sort | circulating thyrotropin receptor messenger ribonucleic acid is not an effective marker in the follow-up of differentiated thyroid carcinoma |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523908/ https://www.ncbi.nlm.nih.gov/pubmed/26244057 http://dx.doi.org/10.1186/s13044-015-0024-4 |
work_keys_str_mv | AT ausavaratsurasawadee circulatingthyrotropinreceptormessengerribonucleicacidisnotaneffectivemarkerinthefollowupofdifferentiatedthyroidcarcinoma AT sriprapapornjiraporn circulatingthyrotropinreceptormessengerribonucleicacidisnotaneffectivemarkerinthefollowupofdifferentiatedthyroidcarcinoma AT satayabanbusara circulatingthyrotropinreceptormessengerribonucleicacidisnotaneffectivemarkerinthefollowupofdifferentiatedthyroidcarcinoma AT thongnoppakhunwanna circulatingthyrotropinreceptormessengerribonucleicacidisnotaneffectivemarkerinthefollowupofdifferentiatedthyroidcarcinoma AT laipiriyakunaunchalee circulatingthyrotropinreceptormessengerribonucleicacidisnotaneffectivemarkerinthefollowupofdifferentiatedthyroidcarcinoma AT amornkitticharoenboontham circulatingthyrotropinreceptormessengerribonucleicacidisnotaneffectivemarkerinthefollowupofdifferentiatedthyroidcarcinoma AT chanachairujaporn circulatingthyrotropinreceptormessengerribonucleicacidisnotaneffectivemarkerinthefollowupofdifferentiatedthyroidcarcinoma AT pattanachakchaveevan circulatingthyrotropinreceptormessengerribonucleicacidisnotaneffectivemarkerinthefollowupofdifferentiatedthyroidcarcinoma |